We describe experiments to investigate the functions of the eosinophil leukocyte. Present information suggests that eosinophils mediate immunity to parasites by attacking and killing susceptible forms of the parasite. One of the mechanisms by which eosinophils kill is the secretion of the eosinophil granule major basic protein (MBP) onto the surface of the parasite. Our previous results point to a role for the eosinophil and the MBP in tissue damage. In this proposal we plan to investigate further the ability of the various forms of MBP to damage cells and tissues, including mast cells, bronchial epithelium and skin. MBP will be tested alone and with eosinophil peroxidase, halide and hydrogen peroxide. Inhibitors of MBP cytotoxicity will be sought. The possibility that the eosinophil damage tissues through an innocent bystander mechanism will be tested. We will attempt to establish an animal model showing the pathologic features of bronchial asthma. The hypothesis that eosinophils damage helminthic parasites will be tested by determining whether MBP is localized to the parasite. Monoclonal antibodies to eosinophils will be produced and their ability to ablate eosinophils will be tested. Finally the monoclonal antibodies will be used to determine the role of the eosinophil in fertility.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37AI009728-17A1
Application #
3480534
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1978-05-01
Project End
1991-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
17
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Behroozian, Adam A; Chludzinski, Jeffrey P; Lo, Eugene S et al. (2013) Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping. Infect Control Hosp Epidemiol 34:961-966
Natarajan, Mukil; Walk, Seth T; Young, Vincent B et al. (2013) A clinical and epidemiological review of non-toxigenic Clostridium difficile. Anaerobe 22:1-5
Feglo, Patrick; Adu-Sarkodie, Yaw; Ayisi, Lord et al. (2013) Emergence of a novel extended-spectrum-?-lactamase (ESBL)-producing, fluoroquinolone-resistant clone of extraintestinal pathogenic Escherichia coli in Kumasi, Ghana. J Clin Microbiol 51:728-30
Waslawski, Sheila; Lo, Eugene S; Ewing, Sarah A et al. (2013) Clostridium difficile ribotype diversity at six health care institutions in the United States. J Clin Microbiol 51:1938-41
Walk, Seth T; Micic, Dejan; Jain, Ruchika et al. (2012) Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 55:1661-8
Gu, Qihai; Lim, Michelle E; Gleich, Gerald J et al. (2009) Mechanisms of eosinophil major basic protein-induced hyperexcitability of vagal pulmonary chemosensitive neurons. Am J Physiol Lung Cell Mol Physiol 296:L453-61
Verbout, Norah G; Jacoby, David B; Gleich, Gerald J et al. (2009) Atropine-enhanced, antigen challenge-induced airway hyperreactivity in guinea pigs is mediated by eosinophils and nerve growth factor. Am J Physiol Lung Cell Mol Physiol 297:L228-37
Plager, Douglas A; Davis, Mark D P; Andrews, Amy G et al. (2009) Eosinophil ribonucleases and their cutaneous lesion-forming activity. J Immunol 183:4013-20